MAPK Inhibitor Negative Control SB 202474

Error loading your content!

  Catalog number
Select a plan
Unit size
Price ({{currency}}) Your price ({{currency}}) Availability Qty
{{product.sku}} {{product.sku}}
also known as {{product.formattedSku}} 
{{subscriptionDetails.selectedRatePlan.billingPeriod}} {{subscriptionDetails.selectedRatePlan.billingPeriod}} {{product.availability.message}}
Pro add-ons

Your on-site stock

›› {{supplyCenter.scName}}({{scProduct.stockOnHand}} In stock)
›› {{supplyCenter.scName}}(Out of stock)
›› {{supplyCenter.scName}}
This item is not currently available on-site. Depending on your Supply Center settings you may be able to add the item to cart above else use the Order Non-Stocked Items' tab on the Supply Center home page.
Back to top


SB 202474, an inactive analog of SB202190 and SB203580, is a negative control for mitogen-activated protein kinase (MAPK) inhibition studies. This compound and its active analogues are useful for elucidating the role of p38 MAPK in affording protection against apoptotic stimuli.

Format/Formulation: Beige solid
For Research Use Only. Not for use in diagnostic procedures.


Form: Solid
Sterility: Nonsterile
Product Size: 1 mg
Purification: HPLC
Inhibitor Type: Kinase Inhibitor (MAP Kinase Inhibitor), Kinase Inhibitor, Inhibitor Control
Molecular Weight: 279.3 Da
Inhibitor Properties: Chemical
Specific Inhibitor Target: None (Control)
Shipping Condition: Dry Ice

Contents & storage

Store in freezer (-5 to -30°C).


Manuals & protocols

Recommended products